CoChat

Genetics Insight for COVID-19 Susceptibility and Severity: A Review

Open access
Fricke-Galindo, Ingrid, Falfán-Valencia, Ramcés · 2021 · Frontiers in Immunology
Cited by 197

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Coronavirus disease (COVID-19) presents a broad spectrum of clinical manifestations ranging from an asymptomatic to a severe clinical course. The host genetic background influence on the susceptibility and outcome of multiples infectious diseases has been previously reported. Herein, we aimed to describe relevant identified genetic variants and those potentially related to the inter-individual variability of COVID-19 susceptibility and/or severity considering the physiopathological pathway of the disease The HLA-A*25:01, -B*15:27,-B*46:01,-C*01:02, and-C*07:29 alleles have been associated with COVID-19 susceptibility; while HLA-A*02:02,-B*15:03, and-C*12:03 have been identified as low-risk alleles. Variants in cytokine genes such as IL1B,IL1R1,IL1RN,IL6,IL17A,FCGR2A, and TNF could be related to disease susceptibility and cytokine storm, and/or COVID-19 complications (e.g., venous thrombosis). Several variants in ACE2 and TMPRSS2 affecting the expression of the receptors related to COVID-19 have been associated with the disease susceptibility and risk factors. Finally, two GWAS have identified the loci 3p21.31 (LZTFL1,SLC6A20,CCR9,FYCO1,CXCR6, and XCR1) and 9q34.2 (ABO) with COVID-19 severity. Heterogeneous results in the association of genetic variants with COVID-19 susceptibility and severity were observed. The mechanism of identified risk-genes and studies in different populations are still warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2021.622176

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Metadata

Authors
Fricke-Galindo, I., & Falfán-Valencia, R.
Venue
Frontiers in Immunology
Published
2021-04-01
Volume
12
Pages
622176-622176
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3146509987
Cited by
197
References
14
FWCI
22.16
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetics Insight for COVID-19 Susceptibility and Severity: A Review. https://app.cochat.ai/papers/10.3389/fimmu.2021.622176
The paper
Fricke-Galindo, I., & Falfán-Valencia, R. (2021). Genetics Insight for COVID-19 Susceptibility and Severity: A Review. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.622176

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.